Melbourne, Australia;
31 August 2018 – Batch of OBM-1701 was Successfully Manufactured with High Purity
Melbourne Australia; 5 November 2019 – Key United States Patent covering OBM-1701 Granted
November 5, 2019Oculus Biomed Limited (“OBM”) is pleased to announce a batch of OBM-1701 has been successfully manufactured with the purity of 99.5% (as determined by the HPLC) by Krisan Biotech Co., Ltd.(“Krisan”). Krisan was founded in August, 2015 and is located in Tainan Science Park, Taiwan. Krisan is one of the leading companies which provides CRO/CDMO/CMO services and owns PICS/GMP certificated pilot plant.
